Stuart J. Schnitt, M.D., is chief of breast oncologic pathology for the Dana-Farber/Brigham and Women's Cancer Center, associate director of the Dana-Farber Cancer Institute/Brigham and Women's Hospital Breast Oncology Program, and senior pathologist at Brigham and Women's Hospital.
He is an internationally recognized authority in breast pathology and has published over 200 original articles, review articles, and book chapters. Dr. Schnitt's research focuses on factors associated with the development of breast cancer and features associated with breast cancer recurrence. He currently serves on the editorial board of 13 medical journals and has been selected by his peers to be listed in the books Best Doctors in America and America's Top Doctors.
Can we help guide you?
Create a profile for better recommendations
Tamoxifen (Brand Names: Nolvadex, Soltamox)
Tamoxifen is the oldest and most-prescribed selective estrogen receptor modulator (SERM)....
Breast Cancer Stages
The stage of a breast cancer is determined by the cancer’s characteristics, such as how large it...
Cancer Survivors Overestimate Quality of Their Diets
Most people who have been diagnosed with cancer think they eat a healthy diet, but a study found...